EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Artificial intelligence generated 3D body composition predicts dose modifications in patients undergoing neoadjuvant chemotherapy for rectal cancer

Alex Besson iD, Ke Cao, Ahmed Mardinli, Lara Wirth, Josephine Yeung, Rory Kokelaar, Peter Gibbs, Fiona Reid, Justin M Yeung

Journal of Cancer Research and Clinical Oncology · 16.05.2025 · 151 (5)

DOI: 10.1007/s00432-025-06219-5 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cancer Research and Clinical Oncology, erschienen am 16.05.2025. Verfasst von Alex Besson und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery - Western Precinct, The University of Melbourne, Melbourne, VIC, Australia. Hauptthemen laut MEDLINE: Rectal Neoplasms, Body Composition, Neoadjuvant Therapy, Artificial Intelligence. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Melbourne.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Chemotherapy administration is a balancing act between giving enough to achieve the desired tumour response while limiting adverse effects. Chemotherapy dosing is based on body surface area (BSA). Emerging evidence suggests body composition plays a crucial role in the pharmacokinetic and pharmacodynamic profile of cytotoxic agents and could inform optimal dosing. This study aims to assess how lumbosacral body composition influences adverse events in patients receiving neoadjuvant chemotherapy for rectal cancer.

Methods

A retrospective study (February 2013 to March 2023) examined the impact of body composition on neoadjuvant treatment outcomes for rectal cancer patients. Staging CT scans were analysed using a validated AI model to measure lumbosacral skeletal muscle (SM), intramuscular adipose tissue (IMAT), visceral adipose tissue (VAT), and subcutaneous adipose tissue volume and density. Multivariate analyses explored the relationship between body composition and chemotherapy outcomes.

Results

242 patients were included (164 males, 78 Females), median age 63.4 years. Chemotherapy dose reductions occurred more frequently in females (26.9% vs. 15.9%, p = 0.042) and in females with greater VAT density (-82.7 vs. -89.1, p = 0.007) and SM: IMAT + VAT volume ratio (1.99 vs. 1.36, p = 0.042). BSA was a poor predictor of dose reduction (AUC 0.397, sensitivity 38%, specificity 60%) for female patients, whereas the SM: IMAT + VAT volume ratio (AUC 0.651, sensitivity 76%, specificity 61%) and VAT density (AUC 0.699, sensitivity 57%, specificity 74%) showed greater predictive ability. Body composition didn’t influence dose adjustment of male patients.

Conclusion

Lumbosacral body composition outperformed BSA in predicting adverse events in female patients with rectal cancer undergoing neoadjuvant chemotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Rectal NeoplasmsBody CompositionNeoadjuvant TherapyArtificial IntelligenceAntineoplastic Combined Chemotherapy ProtocolsHumansFemaleMaleMiddle AgedRetrospective StudiesAgedAdultImaging, Three-DimensionalBody Surface Area

Stichwörter der Autor:innen

Artificial intelligenceBody compositionChemotherapyDose modificationRectal cancer

Autor:innen und Institutionen

  • Department of Surgery - Western Precinct, The University of Melbourne, Melbourne, VIC, Australia.
  • Melbourne Academic Centre for Health, North Melbourne, Melbourne, VIC, Australia.
  • Western Health (Department of Colorectal Surgery), Footscray Hospital, Melbourne, VIC, Australia.
  • Walter and Eliza Hall Institute, Parkville, Melbourne, VIC, Australia.
  • Western Health (Department of Medical Oncology), Footscray Hospital, Melbourne, VIC, Australia.
  • Department of Surgery - Western Precinct, The University of Melbourne, Melbourne, VIC, Australia. justin.yeung@unimelb.edu.au.

ORCID-Profile: Alex Besson

Förderung

  • University of Melbourne

Zitieren

APA

Besson, A., Cao, K., Mardinli, A., Wirth, L., Yeung, J., Kokelaar, R., Gibbs, P., Reid, F., & Yeung, J. M. (2025). Artificial intelligence generated 3D body composition predicts dose modifications in patients undergoing neoadjuvant chemotherapy for rectal cancer. Journal of Cancer Research and Clinical Oncology. https://doi.org/10.1007/s00432-025-06219-5

Vancouver

Besson A, Cao K, Mardinli A, Wirth L, Yeung J, Kokelaar R, et al. Artificial intelligence generated 3D body composition predicts dose modifications in patients undergoing neoadjuvant chemotherapy for rectal cancer. Journal of Cancer Research and Clinical Oncology. 2025. doi:10.1007/s00432-025-06219-5

BibTeX
@article{Besson2025,
  author = {Besson, Alex and Cao, Ke and Mardinli, Ahmed and Wirth, Lara and Yeung, Josephine and Kokelaar, Rory and Gibbs, Peter and Reid, Fiona and Yeung, Justin M},
  title = {Artificial intelligence generated 3D body composition predicts dose modifications in patients undergoing neoadjuvant chemotherapy for rectal cancer},
  journal = {Journal of Cancer Research and Clinical Oncology},
  year = {2025},
  doi = {10.1007/s00432-025-06219-5}
}
Kostenlos starten →